Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Targeted Therapy for Lung Cancer
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing whether it is possible to analyze the genes of patients with lung cancer and cancers of the thymus in order to provide personalized treatment with drugs that target the specific gene abnormalities.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.